New User? Sign Up | Sign In

Insider Trading - Fulcrum Therapeutics Inc. (FULC)

Select Time period:

Enter Stock Symbol or Cik: Cik Lookup...

Search By Company or Insider Name:
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
FULC Insider Trading Transactions for Fulcrum Therapeutics Inc.

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2020-01-23
Sale
2020-01-27
4:28 pm
Fulcrum Therapeutics Inc. FULC Thomson Peter G.
VP
5,000 $17.22 $86,102 33,571
(Direct)
View
2019-07-22
Purchase
2019-07-23
11:39 am
Fulcrum Therapeutics Inc. FULC Sanofi
10% Owner
93,750 $16 $1,500,000 558,035
(Indirect)
View
2019-07-22
Purchase
2019-07-22
4:38 pm
Fulcrum Therapeutics Inc. FULC Third Rock Ventures IV L.P.
Third Rock Ventures GP IV L.P.
TRV GP IV LLC
10% Owner
81,250 $16 $1,300,000 2,343,154
(Direct)
View
2019-07-22
Purchase
2019-07-22
4:34 pm
Fulcrum Therapeutics Inc. FULC Third Rock Ventures III L.P.
Third Rock Ventures GP III L.P.
TRV GP III LLC
STARR KEVIN P
TEPPER ROBERT I
10% Owner
81,250 $16 $1,300,000 5,962,202
(Direct)
View
2019-07-22
Purchase
2019-07-22
4:32 pm
Fulcrum Therapeutics Inc. FULC 6 Dimensions Capital L.P.
10% Owner
118,750 $16 $1,900,000 559,821
(Direct)
View
2019-07-22
Purchase
2019-07-22
4:31 pm
Fulcrum Therapeutics Inc. FULC Casdin Capital LLC
Casdin Partners Master Fund L.P.
Casdin Partners GP LLC
Casdin Eli
10% Owner
140,000 $15.84 $2,217,495 604,285
(Indirect)
View
2019-07-22
Purchase
2019-07-22
4:31 pm
Fulcrum Therapeutics Inc. FULC LEVIN MARK J
Director
10% Owner
81,250 $16 $1,300,000 5,962,202
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2020-01-23
Option Award
2020-01-27
4:31 pm
N/A
2030-01-22
Fulcrum Therapeutics Inc. FULC Stuart Bryan
COO
105,000 $16.87 105,000
(Direct)
View
2020-01-23
Option Award
2020-01-27
4:30 pm
N/A
2030-01-22
Fulcrum Therapeutics Inc. FULC Cadavid Diego
VP
55,440 $16.87 55,440
(Direct)
View
2020-01-23
Option Award
2020-01-27
4:28 pm
N/A
2030-01-22
Fulcrum Therapeutics Inc. FULC Thomson Peter G.
VP
33,100 $16.87 33,571
(Direct)
View
2020-01-23
Option Award
2020-01-27
4:26 pm
N/A
2030-01-22
Fulcrum Therapeutics Inc. FULC Gould Robert J
CEO
200,000 $16.87 200,000
(Direct)
View
2020-01-23
Option Award
2020-01-27
4:25 pm
N/A
2030-01-22
Fulcrum Therapeutics Inc. FULC Wallace Owen B.
Chief Scientific Officer
58,900 $16.87 58,900
(Direct)
View
2020-01-02
Option Award
2020-01-06
09:09 am
N/A
2030-01-01
Fulcrum Therapeutics Inc. FULC Dorton Katina
Director
18,571 $15.86 18,571
(Direct)
View
2019-07-22
Conversion
2019-07-24
4:01 pm
N/A
N/A
Fulcrum Therapeutics Inc. FULC GLAXOSMITHKLINE PLC
10% Owner
1,785,714 $0 0
(Indirect)
View
2019-07-22
Conversion
2019-07-24
4:01 pm
N/A
N/A
Fulcrum Therapeutics Inc. FULC GLAXOSMITHKLINE PLC
10% Owner
12,500,000 $0 0
(Indirect)
View
2019-07-22
Conversion
2019-07-23
11:39 am
N/A
N/A
Fulcrum Therapeutics Inc. FULC Sanofi
10% Owner
464,285 $0 558,035
(Indirect)
View
2019-07-22
Conversion
2019-07-23
11:39 am
N/A
N/A
Fulcrum Therapeutics Inc. FULC Sanofi
10% Owner
3,250,000 $0 558,035
(Indirect)
View
2019-07-22
Conversion
2019-07-22
4:38 pm
N/A
N/A
Fulcrum Therapeutics Inc. FULC Third Rock Ventures IV L.P.
Third Rock Ventures GP IV L.P.
TRV GP IV LLC
10% Owner
2,261,904 $0 2,343,154
(Direct)
View
2019-07-22
Conversion
2019-07-22
4:38 pm
N/A
N/A
Fulcrum Therapeutics Inc. FULC Third Rock Ventures IV L.P.
Third Rock Ventures GP IV L.P.
TRV GP IV LLC
10% Owner
15,833,333 $0 2,343,154
(Direct)
View
2019-07-22
Conversion
2019-07-22
4:34 pm
N/A
N/A
Fulcrum Therapeutics Inc. FULC Third Rock Ventures III L.P.
Third Rock Ventures GP III L.P.
TRV GP III LLC
STARR KEVIN P
TEPPER ROBERT I
10% Owner
5,595,238 $0 5,962,202
(Direct)
View
2019-07-22
Conversion
2019-07-22
4:34 pm
N/A
N/A
Fulcrum Therapeutics Inc. FULC Third Rock Ventures III L.P.
Third Rock Ventures GP III L.P.
TRV GP III LLC
STARR KEVIN P
TEPPER ROBERT I
10% Owner
39,166,668 $0 5,962,202
(Direct)
View
2019-07-22
Conversion
2019-07-22
4:34 pm
N/A
N/A
Fulcrum Therapeutics Inc. FULC Third Rock Ventures III L.P.
Third Rock Ventures GP III L.P.
TRV GP III LLC
STARR KEVIN P
TEPPER ROBERT I
10% Owner
0 $0 5,962,202
(Direct)
View
2019-07-22
Conversion
2019-07-22
4:32 pm
N/A
N/A
Fulcrum Therapeutics Inc. FULC 6 Dimensions Capital L.P.
10% Owner
441,071 $0 559,821
(Direct)
View
2019-07-22
Conversion
2019-07-22
4:32 pm
N/A
N/A
Fulcrum Therapeutics Inc. FULC 6 Dimensions Capital L.P.
10% Owner
3,087,500 $0 559,821
(Direct)
View
2019-07-22
Conversion
2019-07-22
4:31 pm
N/A
N/A
Fulcrum Therapeutics Inc. FULC Casdin Capital LLC
Casdin Partners Master Fund L.P.
Casdin Partners GP LLC
Casdin Eli
10% Owner
464,285 $0 604,285
(Indirect)
View
2019-07-22
Conversion
2019-07-22
4:31 pm
N/A
N/A
Fulcrum Therapeutics Inc. FULC Casdin Capital LLC
Casdin Partners Master Fund L.P.
Casdin Partners GP LLC
Casdin Eli
10% Owner
3,250,000 $0 604,285
(Indirect)
View
2019-07-22
Conversion
2019-07-22
4:31 pm
N/A
N/A
Fulcrum Therapeutics Inc. FULC LEVIN MARK J
Director
10% Owner
5,595,238 $0 5,962,202
(Indirect)
View
2019-07-22
Conversion
2019-07-22
4:31 pm
N/A
N/A
Fulcrum Therapeutics Inc. FULC LEVIN MARK J
Director
10% Owner
39,166,668 $0 5,962,202
(Indirect)
View
2019-07-22
Conversion
2019-07-22
4:30 pm
N/A
N/A
Fulcrum Therapeutics Inc. FULC Section 32 Fund 2 LP
Section 32 GP 2 LLC
Maris William J
10% Owner
464,285 $0 0
(Direct)
View
2019-07-22
Conversion
2019-07-22
4:30 pm
N/A
N/A
Fulcrum Therapeutics Inc. FULC Section 32 Fund 2 LP
Section 32 GP 2 LLC
Maris William J
10% Owner
3,250,000 $0 0
(Direct)
View
2019-07-18
Option Award
2019-07-18
5:28 pm
N/A
2029-07-17
Fulcrum Therapeutics Inc. FULC Wallace Owen B.
Chief Scientific Officer
44,493 $16 44,493
(Direct)
View
2019-07-18
Option Award
2019-07-18
5:28 pm
N/A
2029-07-17
Fulcrum Therapeutics Inc. FULC Collins James J.
Director
5,714 $16 5,714
(Direct)
View
2019-07-18
Option Award
2019-07-18
5:28 pm
N/A
2029-07-17
Fulcrum Therapeutics Inc. FULC GERAGHTY JAMES A
Director
9,285 $16 9,285
(Direct)
View
2019-07-18
Option Award
2019-07-18
5:27 pm
N/A
2029-07-17
Fulcrum Therapeutics Inc. FULC Ezekowitz Alan
Director
5,714 $16 5,714
(Direct)
View
2019-07-18
Option Award
2019-07-18
5:27 pm
N/A
2029-07-17
Fulcrum Therapeutics Inc. FULC Haviland Kate
Director
9,285 $16 9,285
(Direct)
View
2019-07-18
Option Award
2019-07-18
5:27 pm
N/A
2029-07-17
Fulcrum Therapeutics Inc. FULC Gould Robert J
Director
10% Owner
107,142 $16 107,142
(Direct)
View
2019-07-18
Option Award
2019-07-18
5:26 pm
N/A
2029-07-17
Fulcrum Therapeutics Inc. FULC Cadavid Diego
See Remarks
12,784 $16 12,784
(Direct)
View
2019-07-18
Option Award
2019-07-18
5:26 pm
N/A
2029-07-17
Fulcrum Therapeutics Inc. FULC Stuart Bryan
COO
28,571 $16 28,571
(Direct)
View
2019-07-18
Option Award
2019-07-18
5:26 pm
N/A
2029-07-17
Fulcrum Therapeutics Inc. FULC Thomson Peter G.
See Remarks
7,078 $16 7,078
(Direct)
View